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Summary: Leucocyte alkaline phosphatase activity was determined in both cell homogenates and cell extracts.
Leucocytes were obtained from normal controls, pregnant females, and patients with various haematological dis-
orders.
Enzyme activity presented in terms of phosphorus per minute per 108 neutrophils was more in agreement with
the reported cytochemical data in both normal and pathological cases, than the values expressed in terms of
phosphorus per minute per 108 leucocytes or per protein. This was explained by the possible low enzyme activity of
lymphocytes included in the latter. Cases of acute and chronic granulocytic leukaemias showed very low activity
compared to normal ^  irrespective of the method of presentation of activity.
Characterization of leucocyte alkaline phosphatase isoenzyme in normal subjects, using substrate specificities and
selective inhibition tests, showed that it is largely similar to that of liver, bone, kidney and spleen, but differs
markedly from those of the intestine and placenta. In this respect, the leucocyte alkaline phosphatase in pathological
cases showed no variation from normal, except in cases of acute and chronic granulocytic leukaemias and pregnancy,
where the leucocyte alkaline phosphatase enzyme showed a tendency to be heat resistant. In addition, the enzyme
from acute gramdocytic leukaemia eases showed ä higher affinity for -naphthylphosphate, o-carboxyphenyl-
phosphate, and adenosine S'-monophosphate.
Charakterisierung der alkalischen Phosphatase von Leukocyten bei Normalpersonen und unter verschiedenen physio-
logischen und pathologischen Bedingungen
Zusammenfassung: Die Aktivität der alkalischen Phosphatase von Leukocyten wurde in Zellhomogenaten und Zell-
extrakten untersucht. Die Leukocyten stammten von normalen Kontrollpersonen, Schwangeren und Patienten mit
verschiedenen hämatologischen Störungen,
Der Bezug der Enzymaktivität als freigesetztes Phosphat in /min auf l O8 Neutrophile stimmte in normalen und
pathologischen Fällen besser -mit den berichteten cytochemischen Daten überein als die Angabe in /miol/min · l O8
Leukocyten oder in /zmol/imin · g Protein. Dies wird auf die möglicherweise geringe Enzymaktivität der Lympho-
cyteii erklärt. Fälle von akuter und chronischer granulocytärer Leukämie zeigten - welche Bezugsgröße auch ge-
wählt wurde —, verglichen mit Normalpersonen, eine sehr geringe Aktivität.
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Die Charakterisierung der Isoenzyme der alkalischen Phösphatase von Normalpersonen wurde anhand von Substrat-
spezifitäten und selektiven Hemmtests durchgeführt und zeigte, daß das Spektrum in hohem Maße der Gruppe von
Leber-, Knochen-, Urin- und Milz-Isoenzymen ähnlich, jedoch von der von Darm und Placenta deutlich unterschied-
lich ist. Die alkalische Phösphatase von Leukocyten zeigte in dieser Hinsicht in pathologischen Fällen keinen Unter-
schied zu Normalpersönen, jedoch zeigte die alkalische Phösphatase in Fällen von akuter und chronischer granulo-
cytotischer Leukämie und in der Schwangerschaft eine Tendenz zur Hitzeresistenz. Außerdem zeigte sich bei Fällen
von akuter granulocytotischer Leukämie eine höhere Affinität gegenüber -Naphthylphosphat, o-Carboxyphenyl-
phosphat und AMP.
Introduction
The clinical usefulness of leucocyte alkaline phösphatase
determinations has been widely studied. Thus, a de-
creased enzyme activity was found in patients with
chronic granulocytic leukaemia (1, 2). Elevations of
enzyme activity have been reported in several diseased
conditions associated with reactive leucocytosis of the
granulocytic type (2).
The possible heterogeneity of human leucocyte alkaline
phösphatase was documented by Trubowitz et al (3)
in studies of the magnesium ion and zinc ion require-
ments of the enzyme. Isoenzymes of leucocyte alkaline
phösphatase have been demonstrated by several tech-
niques, using starch gel electrophoresis (4-7) and agar
gel electrophoresis (8). However, confusing results have
been found in the literature, concerning the normal
patterns of these isoenzymes (4, 7,9).
The aim of the present work is, firstly, to show in
what respect leucocyte alkaline phösphatase is similar
to organ alkaline phösphatase isoenzymes. Secondly,
to find out whether the enzyme in physiological and
pathological conditions differs from that of normal
subjects.
Materials and Methods
Selection of cases
The material studied in this work was obtained from 28 normal
controls within the age range of 5-70 years (blood bank donors,
laboratory staff or their relatives), 6 pregnant females (physio-
logical leucocytosis), and 119 patients with various haemäto logic
disorders presenting to the Cancer Institute outpatient clinic.
In each case, the diagnosis was initially established on clinical
findings, peripheral blood and bone marrow examination.
Biopsy from the affected organs was resorted to in the diagnosis
of lymphomas and solid tumours. All the cases were subjected
to the present study before receiving any kind of treatment.
Preparation of leucocytes
The separation of leucocytes was carried out according to
Peacock et al (10) with slight modification. The leucocyte pre-
paration was freed of most contaminating erythrocy tes by
exposure to hypotonic saline (6). Total and differential white
cell counts were performed in cell preparation to determine the
percentage of mature granulocytes.
Purified preparations of leucocyte alkaline phösphatase
enzyme
Enzyme extraction from leucocytes was carried out by n~
butanol according to Bottomley et al (11). 8-10 mi leucocyte
cell preparation with a known total and differential white cell
count prepared as above were used for this purpose. The clear
aqueous layer which contains all the enzyme activity was stored
at - 20° C for biochemical analysis.
Preparation of purified alkaline phösphatase enzyme from liver,
bone, kidney, spleen, placenta, and intestine was performed
using /z^butanol, as described above for leucocyte alkaline phös-
phatase. The organs were obtained from postmortem patients
immediately after death. The placenta was taken from full term
pregnant females soon after delivery.
Enzyme assay
The leucocyte alkaline phösphatase activity was estimated by
two techniques. In the first method, 0-glycerophosphate was
utilized as a substrate, and the liberated phosphorus was
estimated colorimetrically at 640 run according to Fiske &
Subbarow (12). The second method is based on determining the
amount of yellow colour of p-nitrophenol that is liberated
from the colourless p-nitrophenylphosphate. The reaction was
stopped by adding 2.5 ml of 0.05 mol/1 NaOH, and the colour
was read at 410 nm. The incubation medium of total volume of
0.5 ml consisted of tris-buffer pH 9.5, 200 mmol/1, substrate.
10 fnmol/1, and MgCl2 5 mmof/l. The readings were compared
with those obtained from standard phosphorus and p-nitro-
phenol on calibrated curves. The enzyme activity was calculated
either as or ing phosphorus or p-nitrophenol released per
108 leucocytes, or per 10* neutrophils, or per gram protein.
The protein content of the cell homogenate, cell extract, and
plasma was estimated by the biuret method of Gornall et al (13).
Results
The levels of leucocyte alkaline phösphatase activity in
normal physiological, and pathological conditions,
using /3-glycerophosphate as a substrate are shown in
table 1. In all cases investigated, the mean values for the
enzyme activity of purified preparations were, on
average, 1.6 times (range 1.4-1.9) higher than that of
cell homogenate, when the activity was expressed as
per 108 leucocytes or 108 neutrophils, whereas it was
7 times higher when represented per gram protein of
leucocytes.
In all types of acute or chronic leukaemias and
lyrriphosarcoma the enzyme activity expressed either as
per 108 leucocytes or gram protein of leucocytes showed
a remarkable decrease from the normal Values (ranging
from 43-98%), while they showed a highly significant
increase above the normal level (range 48-157%) when
activity was expressed as per 108 neutrophils, except in
the case of acute and chronic granulocytic leukaemias,
which still showed values that were 8—18% of normal.
Cases of myelosclerosis, Hodgkirfs disease, and other
malignancies of a non-haemopoietic nature (such as lung,
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breast, bladder) showed no significant changes from
that of normal level. On the other hand, reticulum cell
sarcoma, leukaemoid reaction, and pregnancy showed
very highly significant increases from 47 to 624% above
the normal values, irrespective of the method of ex-
pressing the activity. Multiple myeloma showed a signif-
icant increase when the activity was expressed as per
108 leucocytes or per 108 neutrophils (57-94%), and a
20% decrease, or no change, when the activity was
expressed per gram protein of leucocytes.
Comparative studies of specific activities of alkaline
phosphatase in plasma and purified enzyme preparation
of leucocytes, of normal and different physiological and
pathological conditions were carried out using /3-glycero-
phosphate and p-nitrophenylphosphate as substrates. It
was found that the rate of hydrolysis of p-nitrophenyl-
phosphate by the plasma alkaline phosphatase was
twice that of /3-glycerophosphate (/3-glycerophosphate
to p-nitrophenylphosphate ratio equals 0.54) in normal
and all other conditions, except in pregnancy, when
the activity ratio of /3-glycerophosphate to p-nitro-
phenylphosphate was equal to 1.36. In all the patholog-
ical cases investigated the enzyme level of the plasma
was the same as that in normal individuals, while in
pregnancy, the plasma enzyme increased by 360% above
normal using /3-glycerophosphate as substrate. On the
other hand, the alkaline phosphatase activity in the
purified enzyme preparation of leucocytes showed
equal affinity to both /3-glycerophosphate and p-nitro-
phenylphosphate, in both normal and other conditions,
except in pregnancy, where the enzyme showed a lower
affinity for p-nitrophenylphosphate (/3-glycerophos-
phate to p-nitrophenylphosphate ratio equals 0.84).
Characterization of the alkaline phosphatase isoenzyme
of different organ tissues and leucocytes was carried
out with respect to substrate specificities and selective
inhibition. Table 2 presents the results obtained with
different substrates comparing a purified preparation of
normal leucocyte alkaline phosphatase with tissue
alkaline phosphatase from liver, kidney, bone, spleen,
intestine, and placenta. Taking the activity with /3-
glycerophosphate as 100%, the leucocyte alkaline
phosphatase from normal subjects catalyses the hydro-
lysis of p-nitrophenylphosphate and a-naphthylphosphate
equally, but the activity is slightly less than with )3-
gtycerophosphate (about 15% less), while with o-
carboxyphenylphosphate and adenosine-5'mono-
phosphate the rate of hydrolysis was less than that
of /3-glycerophosphate by 50 and 32% respectively. This
was in agreement with the values obtained with liver,
kidney, bone, and spleen isoenzymes, and differs from
that of intestinal and placental isoenzymes. The latter
showed a higher affinity for ocarboxyphenylphosphate
and adenosine-S'monophosphate than for 0-glycero-
phosphate by 19 and 40% respectively, while with
p-nitrophenylphosphate and α-naphthylphosphate the
activity was less than that observed with /3-glycero-
phosphate by about 50%.
Comparison between normal leucocyte alkaline phos-
phatase and that in different physiological and patholo-
gical conditions with respect to substrate specificities is
represented in table 3. No significant differences were
observed between the enzyme activities from acute or
chronic leukaemias, lymphomas and normal persons,
except in the case of acute granulocytic leukaemia which
showed an activity significantly higher than normal
when ά-naphthylphosphate, o-carboxyphenylphosphate
and adenosine-S'-monophosphate were used (P < 0.05).
In pregnancy and leukaemoid conditions, there was a
higher affinity to both p-nitrophenylphosphate and
α-naphthylphosphate (P < 0.005, P < 0.05 respectively).
Table 2 shows the results of selective inhibition using
L-phenylalanine, taurocholate, urea, zinc ions, cysteine,
and heating at 56°C (30 min at pH 7.0). The.normal
leucocyte inhibitory pattern was similar to that obtained
from purified enzyme preparation of liver, kidney,
bone, and spleen isoenzymes, but remarkably different
from that of intestinal and placental isoenzymes. The
latter two isoenzymes showed marked resistance to
heat treatment, and sensitivity to inhibition by L-
phenylalanine, but not by taurocholate.
There was no significant difference in the behaviour of
normal leucocyte alkaline phosphatase and that of
leukaemias towards the above-mentioned treatments;
with the exception of acute and chronic granulocytic
leukaemias which behaved differently from normal with
respect to heat treatment and inhibition by cysteine. The
latter were found to be heat resistant and more sensitive
to inhibition by cysteine, thus resembling the leucocyte
alkaline phosphatase in pregnancy (tab. 3).
Discussion
Analysis of the biochemical data obtained from the
present study showed that the enzyme activity repre-
sented in terms of μπιοί phosphorus per minute per
108 neutrophils was more in agreement with the
reported cyt chemical data in both normal and
pathological cases, than that expressed in terms of
μτηοΐ phosphorus per minute per 108 leucocytes
(14-15). This may be due to the low enzyme activity
of lymphocytes included in the latter calculation.
Cyt chemical studies showed no or very low enzyme
activity in lymphocytes (14-18). Park (17) reported
the presence of two leucocyte alkaline phosphatase iso-
enzymes; one is located in neutrophils and catalyses
the hydrolysis of/3-glycerophosphate andp-nitn>
phenylphosphate equally; the other is present in
lymphocytes and catalyses the hydrolysis of/3-
glycerophosphate only. However, in the present study,
the leucocyte alkaline phosphatase of the purified
preparation catalysed the hydrolysis of /3-glycerophos-
phate and p-nitrophenylphosphate nearly equally.
Attempts to characterize the leucocyte alkaline phos-
phatase isoenzyme in normal leucocytes, showed that
J. Clin. Chem. Clin. Bipchem. / VoL 15,1977 / No. 11
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it is largely similar to the group of liver, bone, kidney,
and spleen isoenzymes, but markedly differs from
the intestinal or placental ones (Table 2). This was in
respect to substrate specificities and selective inhibition.
Leucocyte alkaline phosphatase of lymphomas and
leukaemias was similar to that of normal with regard to
substrate specificities and inhibition, except in case of
acute and chronic granulocytic leukaemia. The evaluation
of these data and its use in diagnosis has to be considered.
The results of Lyons et al (20) appeared to be consistent
with the above findings with regard to that of heat
inactivation and L-phenylalanine inhibition. However,
Bottomley et al (11) observed that i-phenylalanine
inhibited the enzyme from normal, chronic granulocytic
leukaemia, and reactive granulocytosis in an uncom-
petitive manner. They suggested that the enzyme may
belong to the intestinal and placenta! phosphatases,
since inhibition of intestinal phosphatase by L-phenyl-
alanine has been reported by several authors (21—24),
and inhibition of human placental phosphatase by the
same agent was reported by Fishman et al (22). How-
ever, in the present study, more comparative studies,
including the use of various substrates and the effect
of different inhibitors, showed that the leucocyte
alkaline phosphatase does not belong to either the
placental or intestinal alkaline phosphatases.
The data presented on the affinity of serum alkaline
phosphatase and leucocyte alkaline phosphatase for
/3-glycerophosphate and p-nitrophenylphosphate, showed
that serum alkaline phosphatase is different from that
of the leucocyte enzyme. Also it suggested that the
high serum alkaline phosphatase in pregnancy is not of
leucocyte origin.
Studies on the electrophoretic pattern of leucocyte
alkaline phosphatase in normal individuals by Rosen-
blum &Petzold (19) revealed one single band. Lyons
et al (20) observed three enzyme bands, but occasionally
detected 2 or 3 bands simultaneously in their cases.
However, they suggested that the variable electrophoretic
mobility does not establish the existence of multiple
forms of the enzyme, since an apparent isoenzyme may
result from artifacts such as molecular aggregation or
depolymerization, or when an enzyme binds to a carrier
molecule.
Robinson et al (4, 25) reported a distinguished
leukaemic pattern of electrophoretic mobility of
leucocyte alkaline phosphatase in chronic granulo-
cytic leukaemia. Other investigators (26-27) observed
that the distribution of leucocyte alkaline phosphatase
isoenzyme in chronic granulocytic leukaemia corre-
sponded to that of normal cases.
Bottomley et al (11) reported that similar amounts of
enzyme protein could show different enzyme activity.
Thus, the enzyme from chronic granulocytic leukaemia
had low specific activity, the enzyme from normal
leucocytes had intermediate specific activity, and the
enzyme from patients with reactive granulocytosis had
a very high specific activity. The authors suggested that
this could be related to an increase or decrease of
active sites on the enzyme molecule, resulting in
marked changes in the specific activity of the enzyme
molecule.
Rosenblum &Petzold (19) also could not detect any
qualitative difference between the leucocyte alkaline
phosphatase in normals, patients with chronic granulo-
cytic leukaemia, and polycythemic patients with
regard to molecular weight, inhibition studies, electro-
phoretic pattern or immunologic characterization. The
authors suggested a quantitative difference that could
be the responsible factor for the fluctuations in the
enzyme specific activity.
From the above study, it can be concluded that there
seems to be only one leucocyte alkaline phosphatase
enzyme which is probably subjected to the physiological
status and/or environment of the individual. In emer-
gency situations, such as severe leucocytosis, a rapid
turnover occurs, resulting in an increased rate of pro-
duction of granulocytes, associated with an immediate
release of a population of newly-formed granulocytes
which contain alkaline phosphatase enzyme that may
differ in its physical properties from that present in the
mature granulocytes.
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